New Cardio-Oncology Program to keep hearts beating strong throughout breast cancer treatments

NewsGuard 100/100 Score

Hearts are at risk when fighting against breast cancer - due to toxic side effects of common treatments like chemotherapy and radiation therapy. Depending on age and other factors, up to 30 percent of patients receiving chemo therapy or radiation therapy may develop heart damage related to treatment. Orlando Health Heart Institute and UF Health Cancer Center at Orlando Health have developed a new Cardio-Oncology Program to help keep hearts beating strong throughout breast cancer treatments.

The program is made up of a multidisciplinary team including cardiologists, oncologists, advanced nurse practitioners, and other clinicians, working together to protect hearts.

With the program, clinicians evaluate patients prior to receiving treatment for a baseline assessment of their hearts. The baseline helps cardiologists detect changes as they monitor patients throughout the course of cancer treatments. Testing before, during, and after cancer treatments may include echocardiograms, blood tests, and other diagnostics to show markers and indications that a person has heart damage, or is at high risk to develop heart problems. If heart damage is detected, or risk factors are determined, cardiologists and oncologists work together to adjust cancer treatments, or prescribe heart medications. The changes may prevent heart damage, reverse damage, or help stop the damage from getting worse.

Heart problems resulting from cancer treatments include cardiomyopathy - a disease that weakens and enlarges the heart muscle. As the condition worsens it can lead to heart failure or irregular heartbeats. Other potential cardiac conditions include heart attack, arterial valve problems, and damage to the heart membrane.

The program is beginning with a focus on patients being treated for breast cancer who receive chemotherapy or radiation therapy on the left side of their chest. There are future plans to expand the program to help patients with other cancers.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis